The effect of timolol drops on respiratory function

Eye (Basingstoke)

Volumn 12, Issue 3, 1998, Pages 386-389

  Sadiq, S A ^a   Vernon, S A ^a   Fielding, K ^a  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

Adverse drug reactions; Bronchoconstriction; Ocular hypertension; Respiratory function; Timolol

Indexed keywords

GLAUCOL; TIMOLOL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BRONCHUS OBSTRUCTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INTRAOCULAR DRUG ADMINISTRATION; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; LUNG FUNCTION; MALE; PEAK EXPIRATORY FLOW; RANDOMIZED CONTROLLED TRIAL; SUBLINGUAL DRUG ADMINISTRATION; VITAL CAPACITY;

EID: 0031852449     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.1998.91     Document Type: Article

References (11)

1. Diggory P, Heyworth P, Chau G, McKenzie S, Sharma A, Luke I. Improved lung function tests on changing from topical timolol: non-selective beta-blockade impairs lung function tests in elderly patients. Eye 1993;7:661-3.
2. Sadiq SA, Vernon SA. Sublingual timolol: an alternative to topical medication in glaucoma? Br J Ophthalmol 1996;80:532-5.
3. Graft DF, Fowles J, McCoy CE, Lager RA. Detection of 13- blocker use in people with asthma. Ann Allergy 1992;69:449-53.
4. Renwick DS, Connolly MJ. Prevalence and treatment of chronic airways obstruction in older adults. Age Aging 1994;23 (Suppl 2):6.
5. Spaeth G, Birbilis E. The effect of glaucoma and treatment of glaucoma on quality of life. In: Krieglstein E, editor. Glaucoma update, vol 4. Berlin: Springer-Verlag, 1991:2.&-7.
6. Beta-adrenoceptor blocking drugs. In: British national formulary. London: British Medical Association and Royal Pharmaceutical Society of Great Britain, 1995:70-2.
7. Pride NB. Lung function testing. In: Weatherall DJ, Ledingham JGG, Warrell DA, editors. Oxford textbook of medicine, vol 2. New York: Oxford University Press, 1996: 2666-75.
8. Vuori ML, Kaila T. Plasma kinetics and antagonist activity of topical ocular timolol in elderly patients. Graefes Arch Clin Exp Ophthalmol 1995;233:131-4.
9. Avlan G, Calissendorff B, Seideman P, Wid mark K, Widmark G. Absorption of ocular timolol. Clin Pharmacokinet 1980;5:95-100.
10. Zimmerman TJ, Kooner KS, Kandarakis AS, et al. Improving therapeutic index of ocular drugs. Arch Ophthalmol 1984;102:551-3.
11. Olah TV, Gilbert JD, Barrish A. Determination of the l3-adrenergic blocker timolol in plasma by liquid chromatography-atmospheric pressure chemical ionization mass spectrometry. J Pharm Biomed Anal 1993;11:157-63.